Login
$XBIT
$1.85 -$0.11 (5.61%) Close

Ownership

13F as of Q2 2026 · 30.5M shares outstanding

Who owns XBIT?

By type of holder
Institutions 6.5% Insiders 27.4% Everyone else 66.1%
Concentration Top 10 holders own 31.2%
Simard John 14.0% · Mckenzie W Thorpe 11.8%
Institutional ownership
6.5%
-0.0 pts vs last qtr
Institutional holders
36
-1 vs last qtr
Net shares bought
−11.6K
by institutions in Q2 2026
New / sold out
4 / 5
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Gsa Capital Partners LLP NEW +30.7K
  • Citadel Advisors LLC NEW +29.2K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Jane Street Group, LLC −48.6K
  • Millennium Management LLC −26.2K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for XBiotech Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
−5.9%
−0.67% a year
Each share's claim on the business
+6.3%
grew without buying or selling a share
Spent on buybacks vs paid in stock
$14K vs $43.1M
over 10 fiscal years
Diluted shares, split-adjusted
29.1M38.0M46.8M2016: 32.4M shares'162017: 34.9M shares'172018: 35.8M shares'182019: 46.3M shares'192020: 30.8M shares'202021: 30.0M shares'212022: 30.4M shares'222023: 30.4M shares'232024: 30.5M shares'242025: 30.5M shares'25
Buybacks Stock-based comp
$0$6.3M$12.6M2016 buybacks: $02016 stock comp: $5.6M'162017 buybacks: $02017 stock comp: $1.8M'172018 buybacks: $02018 stock comp: $1.7M'182019 buybacks: $02019 stock comp: $3.4M'192020 buybacks: $02020 stock comp: $12.6M'202021 buybacks: $02021 stock comp: $4.5M'212022 buybacks: $02022 stock comp: $5.1M'222023 buybacks: $14.0K2023 stock comp: $3.3M'232024 buybacks: $02024 stock comp: $1.8M'242025 buybacks: $02025 stock comp: $3.6M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years63% 3–5 years13% 1–3 years17% Under 1 year6%
Quarterly turnover
7.1%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting XBIT on Form 13F
B
BlackRock, Inc.
Shares
321.1K
% of company
1.05%
Change vs last qtr
+28.0K (+9.6%)
Held since
≤2021
GC
Geode Capital Management, LLC
Shares
214.1K
% of company
0.70%
Change vs last qtr
−16.9K (−7.3%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding XBiotech Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting XBIT on Form N-PORT; together they hold 1.9% of the company
VE
Position value
$460K
% of company
0.66%
% of the fund
0.00%
As of
June 30, 2026
FE
Fidelity Concord Street Trust
Position value
$215K
% of company
0.31%
% of the fund
0.00%
As of
August 31, 2026

14 more funds behind a free account

See every fund holding XBiotech Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
SJ
Simard John
Insider
Shares
4.3M
% of company
13.98%
Change vs last qtr
—
Held since
—
MW
Mckenzie W Thorpe
Insider
Shares
3.6M
% of company
11.83%
Change vs last qtr
—
Held since
—

2 more holders behind a free account

See every insider and 5%+ holder of XBiotech Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support